Notch2 is preferentially expressed in mature B cells and indispensable for marginal zone B lineage development

Immunity

Volumn 18, Issue 5, 2003, Pages 675-685

  Saito, Toshiki ^a   Chiba, Shigeru ^a   Ichikawa, Motoshi ^a   Kunisato, Atsushi ^a   Asai, Takashi ^a   Shimizu, Kiyoshi ^a   Yamaguchi, Tomoyuki ^a   Yamamoto, Go ^a   Seo, Sachiko ^a   Kumano, Keiki ^a   Nakagami Yamaguchi, Etsuko ^a   Hamada, Yoshio ^b   Aizawa, Shinichi ^c   Hirai, Hisamaru ^a  

^a UNIVERSITY OF TOKYO   (Japan)

^b NATIONAL INSTITUTE FOR BASIC BIOLOGY   (Japan)

^c RIKEN Center for Biosystems Dynamics Research   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD1D ANTIGEN;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; B LYMPHOCYTE; CELL DIFFERENTIATION; CELL LINEAGE; CELL MATURATION; CONTROLLED STUDY; DELTEX1 GENE; GENE; GENE DELETION; GENE EXPRESSION; GENE FUNCTION; GENE INTERACTION; GENE TARGETING; GENETIC ANALYSIS; MOUSE; MULTIGENE FAMILY; NONHUMAN; NOTCH2 GENE; PRIORITY JOURNAL;

EID: 0038742790     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1074-7613(03)00111-0     Document Type: Article

References (47)

1. Amano M., Baumgarth N., Dick M.D., Brossay L., Kronenberg M., Herzenberg L.A., Strober S. CD1 expression defines subsets of follicular and marginal zone B cells in the spleen. beta 2-microglobulin-dependent and independent forms J. Immunol. 161:1998;1710-1717.
2. Artavanis-Tsakonas S., Rand M.D., Lake R.J. Notch signaling. cell fate control and signal integration in development Science. 284:1999;770-776.
3. Bash J., Zong W.X., Banga S., Rivera A., Ballard D.W., Ron Y., Gelinas C. Rel/NF-kappaB can trigger the Notch signaling pathway by inducing the expression of Jagged1, a ligand for Notch receptors. EMBO J. 18:1999;2803-2811.
4. Bertrand F.E., Eckfeldt C.E., Lysholm A.S., LeBien T.W. Notch-1 and Notch-2 exhibit unique patterns of expression in human B- lineage cells. Leukemia. 14:2000;2095-2102.
5. Cariappa A., Liou H.C., Horwitz B.H., Pillai S. Nuclear factor kappa B is required for the development of marginal zone B lymphocytes. J. Exp. Med. 192:2000;1175-1182.
6. Cariappa A., Tang M., Parng C., Nebelitskiy E., Carroll M., Georgopoulos K., Pillai S. The follicular versus marginal zone B lymphocyte cell fate decision is regulated by Aiolos, Btk, and CD21. Immunity. 14:2001;603-615.
7. Cheng P., Zlobin A., Volgina V., Gottipati S., Osborne B., Simel E.J., Miele L., Gabrilovich D.I. Notch-1 regulates NF-kappaB activity in hemopoietic progenitor cells. J. Immunol. 167:2001;4458-4467.
8. Croker B.A., Tarlinton D.M., Cluse L.A., Tuxen A.J., Light A., Yang F.C., Williams D.A., Roberts A.W. The Rac2 guanosine triphosphatase regulates B lymphocyte antigen receptor responses and chemotaxis and is required for establishment of B-1a and marginal zone B lymphocytes. J. Immunol. 168:2002;3376-3386.
9. Dammers P.M., de Boer N.K., Deenen G.J., Nieuwenhuis P., Kroese F.G. The origin of marginal zone B cells in the rat. Eur. J. Immunol. 29:1999;1522-1531.
10. Fukui Y., Hashimoto O., Sanui T., Oono T., Koga H., Abe M., Inayoshi A., Noda M., Oike M., Shirai T., Sasazuki T. Haematopoietic cell-specific CDM family protein DOCK2 is essential for lymphocyte migration. Nature. 412:2001;826-831.
11. Girkontaite I., Missy K., Sakk V., Harenberg A., Tedford K., Potzel T., Pfeffer K., Fischer K.D. Lsc is required for marginal zone B cells, regulation of lymphocyte motility and immune responses. Nat. Immunol. 2:2001;855-862.
12. Guan E., Wang J., Laborda J., Norcross M., Baeuerle P.A., Hoffman T. T cell leukemia-associated human Notch/translocation-associated Notch homologue has I kappa B-like activity and physically interacts with nuclear factor-kappa B proteins in T cells. J. Exp. Med. 183:1996;2025-2032.
13. Guinamard R., Okigaki M., Schlessinger J., Ravetch J.V. Absence of marginal zone B cells in Pyk-2-deficient mice defines their role in the humoral response. Nat. Immunol. 1:2000;31-36.
14. Hamada Y., Kadokawa Y., Okabe M., Ikawa M., Coleman J.R., Tsujimoto Y. Mutation in ankyrin repeats of the mouse Notch2 gene induces early embryonic lethality. Development. 126:1999;3415-3424.
15. Han H., Tanigaki K., Yamamoto N., Kuroda K., Yoshimoto M., Nakahata T., Ikuta K., Honjo T. Inducible gene knockout of transcription factor recombination signal binding protein-J reveals its essential role in T versus B lineage decision. Int. Immunol. 14:2002;637-645.
16. Hoffmann R., Seidl T., Neeb M., Rolink A., Melchers F. Changes in gene expression profiles in developing B cells of murine bone marrow. Genome Res. 12:2002;98-111.
17. Kaneta M., Osawa M., Sudo K., Nakauchi H., Farr A.G., Takahama Y. A role for pref-1 and HES-1 in thymocyte development. J. Immunol. 164:2000;256-264.
18. Kawamata S., Du C., Li K., Lavau C. Overexpression of the Notch target genes Hes in vivo induces lymphoid and myeloid alterations. Oncogene. 21:2002;3855-3863.
19. Kraus M., Pao L.I., Reichlin A., Hu Y., Canono B., Cambier J.C., Nussenzweig M.C., Rajewsky K. Interference with immunoglobulin (Ig)alpha immunoreceptor tyrosine-based activation motif (ITAM) phosphorylation modulates or blocks B cell development, depending on the availability of an Igbeta cytoplasmic tail. J. Exp. Med. 194:2001;455-469.
20. Kuhn R., Schwenk F., Aguet M., Rajewsky K. Inducible gene targeting in mice. Science. 269:1995;1427-1429.
21. Loder F., Mutschler B., Ray R.J., Paige C.J., Sideras P., Torres R., Lamers M.C., Carsetti R. B cell development in the spleen takes place in discrete steps and is determined by the quality of B cell receptor-derived signals. J. Exp. Med. 190:1999;75-89.
22. Lu T.T., Cyster J.G. Integrin-mediated long-term B cell retention in the splenic marginal zone. Science. 297:2002;409-412.
23. Makar K.W., Ulgiati D., Hagman J., Holers V.M. A site in the complement receptor 2 (CR2/CD21) silencer is necessary for lineage specific transcriptional regulation. Int. Immunol. 13:2001;657-664.
24. Makowska A., Faizunnessa N.N., Anderson P., Midtvedt T., Cardell S. CD1high B cells. a population of mixed origin Eur. J. Immunol. 29:1999;3285-3294.
25. Martin F., Kearney J.F. Positive selection from newly formed to marginal zone B cells depends on the rate of clonal production, CD19, and btk. Immunity. 12:2000;39-49.
26. Mumm J.S., Kopan R. Notch signaling. from the outside in Dev. Biol. 228:2000;151-165.
27. Ohishi K., Varnum-Finney B., Flowers D., Anasetti C., Myerson D., Bernstein I.D. Monocytes express high amounts of Notch and undergo cytokine specific apoptosis following interaction with the Notch ligand, Delta-1. Blood. 95:2000;2847-2854.
28. Ordentlich P., Lin A., Shen C.P., Blaumueller C., Matsuno K., Artavanis-Tsakonas S., Kadesch T. Notch inhibition of E47 supports the existence of a novel signaling pathway. Mol. Cell. Biol. 18:1998;2230-2239.
29. Osborne B., Miele L. Notch and the immune system. Immunity. 11:1999;653-663.
30. Oswald F., Liptay S., Adler G., Schmid R.M. NF-kappaB2 is a putative target gene of activated Notch-1 via RBP-Jkappa. Mol. Cell. Biol. 18:1998;2077-2088.
31. Pillai S. The chosen few? Positive selection and the generation of naive B lymphocytes. Immunity. 10:1999;493-502.
32. Radtke F., Wilson A., Stark G., Bauer M., van Meerwijk J., MacDonald H.R., Aguet M. Deficient T cell fate specification in mice with an induced inactivation of Notch1. Immunity. 10:1999;547-558.
33. Rickert R.C., Rajewsky K., Roes J. Impairment of T-cell-dependent B-cell responses and B-1 cell development in CD19-deficient mice. Nature. 376:1995;352-355.
34. Rickert R.C., Roes J., Rajewsky K. B lymphocyte-specific, Cre-mediated mutagenesis in mice. Nucleic Acids Res. 25:1997;1317-1318.
35. Roark J.H., Park S.H., Jayawardena J., Kavita U., Shannon M., Bendelac A. CD1.1 expression by mouse antigen-presenting cells and marginal zone B cells. J. Immunol. 160:1998;3121-3127.
36. Robey E. Regulation of T cell fate by Notch. Annu. Rev. Immunol. 17:1999;283-295.
37. Samardzic T., Marinkovic D., Danzer C.P., Gerlach J., Nitschke L., Wirth T. Reduction of marginal zone B cells in CD22-deficient mice. Eur. J. Immunol. 32:2002;561-567.
38. Sato S., Steeber D.A., Jansen P.J., Tedder T.F. CD19 expression levels regulate B lymphocyte development. human CD19 restores normal function in mice lacking endogenous CD19 J. Immunol. 158:1997;4662-4669.
39. Seo S., Buckler J., Erikson J. Novel roles for Lyn in B cell migration and lipopolysaccharide responsiveness revealed using anti-double-stranded DNA Ig transgenic mice. J. Immunol. 166:2001;3710-3716.
40. Shimizu K., Chiba S., Hosoya N., Kumano K., Saito T., Kurokawa M., Kanda Y., Hamada Y., Hirai H. Binding of Delta1, Jagged1, and Jagged2 to Notch2 rapidly induces cleavage, nuclear translocation, and hyperphosphorylation of Notch2. Mol. Cell. Biol. 20:2000;6913-6922.
41. Strobl L.J., Hofelmayr H., Marschall G., Brielmeier M., Bornkamm G.W., Zimber-Strobl U. Activated Notch1 modulates gene expression in B cells similarly to Epstein-Barr viral nuclear antigen 2. J. Virol. 74:2000;1727-1735.
42. Tanigaki K., Han H., Yamamoto N., Tashiro K., Ikegawa M., Kuroda K., Suzuki A., Nakano T., Honjo T. Notch-RBP-J signaling is involved in cell fate determination of marginal zone B cells. Nat. Immunol. 3:2002;443-450.
43. Tan-Pertel H.T., Walker L., Browning D., Miyamoto A., Weinmaster G., Gasson J.C. Notch signaling enhances survival and alters differentiation of 32D myeloblasts. J. Immunol. 165:2000;4428-4436.
44. Wang J.H., Avitahl N., Cariappa A., Friedrich C., Ikeda T., Renold A., Andrikopoulos K., Liang L., Pillai S., Morgan B.A., Georgopoulos K. Aiolos regulates B cell activation and maturation to effector state. Immunity. 9:1998;543-553.
45. Wang J., Shelly L., Miele L., Boykins R., Norcross M.A., Guan E. Human Notch-1 inhibits NF-kappa B activity in the nucleus through a direct interaction involving a novel domain. J. Immunol. 167:2001;289-295.
46. Weih D.S., Yilmaz Z.B., Weih F. Essential role of RelB in germinal center and marginal zone formation and proper expression of homing chemokines. J. Immunol. 167:2001;1909-1919.
47. Won W.J., Kearney J.F. CD9 is a unique marker for marginal zone B cells, B1 cells, and plasma cells in mice. J. Immunol. 168:2002;5605-5611.